A Call For Give And Take

As former editor of a physics education journal and coauthor of two relativity texts, I have had a lot of contact with what your article [B. Goodman, The Scientist, May 15, 1995, page 3] calls "dissident" scientists, many of whom attack special relativity. In my experience, most are extremely intelligent and inventive. Their arguments are ingenious, and any errors are often difficult to find. Still, there are two characteristics that I have found in many dissidents with whom I have communicated

Written byEdwin Taylor
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Isolation: Most dissidents are not routinely in collegial contact either with professional scientists or with one another. Instead, each typically works alone and approaches others only with what he or she feels are finished theories. The same is true of some small fraction of first-rate scientists, such as P.A.M. Dirac and Julian Schwinger. More often, however, mainstream science occurs in the give and take of a group of colleagues. A major contribution of such a group is to cull out and eliminate unproductive ideas. This is important, because the vast majority of new ideas (I would guess at least 97 percent) prove unproductive. Niels Bohr said that "An expert is [someone] who has made all the mistakes, which can be made, in a very narrow field."

Conventionality: Many dissidents are loyal to Newtonian mechanics and other long-accepted theories that the professional scientific community consider to be limited in validity. In ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies